Profile of:

Daniël Wendling

Full name: Daniël Wendling

Current country: France

Membership level: Full

Type of membership: Member

Number of publications: 54

Impact of NSAIDs on 8-year cumulative incidence of major cardiovascular events in patients with ankylosing spondylitis: a nationwide study (2023)

Influence of Sex on Early Axial Spondyloarthritis: A Six-Year Longitudinal Analysis From a Large National Cohort (2023)

Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries (2023)

Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA) (2023)

Interleukin-23 Blockade Is Not Effective in Axial Spondyloarthritis (2023)

Comparison of sacroiliac CT findings in patients with and without psoriatic arthritis: results of the CASIPSA Study (2023)

Factors associated with remission at 5-year follow-up in recent-onset axial spondyloarthritis: results from the DESIR cohort (2022)

Tight control and treat-to-target in axial spondyloarthritis. Where are we? (2022)

Exploring remission concept in axial spondyloarthritis through the perception of rheumatologists using vignettes and priority ratings (2022)

Differences in distribution by department of prevalence and incidence of spondyloarthritis and inflammatory bowel diseases declared to the French National Health Insurance and their evolution between 2008 and 2018 (2022)

2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis (2022)

Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years (2022)

Systematic assessment of heart valves and cardiac function by echocardiography in axial spondyloarthritis: A systematic review and meta-analysis (2022)

Impact of disease activity outcome measures reporting in the medical records of patients with axial spondyloarthritis on the retention rates of biological treatment: the example of secukinumab use in daily practice in France (2022)

Axial psoriatic arthritis: New entity or clinical form only? (2022)

Subchondral bone attenuation coefficient utility of the sacroiliac margins to differentiate spondyloarthritis and osteitis condensans ilii (2022)

Development and Validation of a Self-Administered Questionnaire Measuring Essential Knowledge in Patients With Axial Spondyloarthritis (2022)

World mortality of ankylosing spondylitis, psoriatic arthritis and inflammatory bowel disease in 2015 and its evolution from 2001 to 2015 (2022)

Frequency and anatomic distribution of magnetic resonance imaging lesions in the sacroiliac joints of spondyloarthritis and non-spondyloarthritis patients (2022)

Is the Difficult-to-Treat (D2T) concept applicable to axial spondyloarthritis? (2022)

Is psoriatic arthritis doomed to disappear? (2022)

Intestinal permeability in spondyloarthritis and rheumatoid arthritis: A systematic review of the literature. Semin Arthritis Rheum. 2021 Aug;51(4):712-718. doi: 10.1016/j.semarthrit.2021.04.015. Epub 2021 May 6. PMID: 34139524. (2021)

Uveitis occurrence in early inflammatory back pain. Five years data from the prospective French nationwide DESIR cohort (2020)

Can SARS-CoV-2 trigger reactive arthritis? (2020)

ASAS Health Index: The “All in One” for Spondyloarthritis Evaluation? (2020)

Deciding who to treat with biologic disease-modifying antirheumatic drugs in axial spondyloarthritis. (2020)

From observational studies to personalized treatment in spondylarthritis: focus on IL-17 inhibition. (2020)

Toward a tailored therapeutic prescription for patients with axial spondyloarthritis. (2020)

Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases. (2020)

Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial. (2020)

Share Reactive Arthritis: Treatment Challenges and Future Perspectives. (2020)

Data to be collected for an optimal management of axial spondyloarthritis in daily practice: Proposal from evidence-based and consensual approaches. (2020)

Prognostic factors of good response to DMARDs in psoriatic arthritis: a narrative review. (2020)

Are the recommendations for the use of anti-TNF drugs during axial spondyloarthritis relevant for non-radiographic forms? (2020)

Ultrasonographic Involvement of the anterior chest wall in Spondyloarthritis: Factors associated with 5-years structural progression. A prospective study in 58 patients. (2020)

5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohort. (2020)

Dactylitis in early spondyloarthritis. Data from the prospective French national cohort DESIR. (2020)

Cardiovascular risk in psoriatic arthritis, a narrative review. (2020)

Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism? (2020)

Local sacroiliac injections in the treatment of spondyloarthritis. What is the evidence? (2020)

Effect of Gut Involvement in Patients with High Probability of Early Spondyloarthritis: Data from the DESIR Cohort. (2020)

New targeted therapies in spondyloarthritis: what are the limits? (2019)

Clinical peripheral enthesitis in the DESIR prospective longitudinal axial spondyloarthritis cohort. (2019)

Anti-IL-17 monoclonal antibodies for the treatment of ankylosing spondylitis. (2019)

Efficacy of new treatments for dactylitis of psoriatic arthritis: update of literature review. (2019)

Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus. (2019)

Aerobic exercise for axial spondyloarthritis – its effects on disease activity and function as compared to standard physiotherapy: A systematic review and meta-analysis. (2019)

Vascular involvement in axial spondyloarthropathies. (2019)

Increase In Il-31 Serum Levels Is Associated With Reduced Structural Damage In Early Axial Spondyloarthritis. (2018)

2018 update of French Society for Rheumatology (SFR) recommendations about the everyday management of patients with spondyloarthritis. (2018)

Disease activity in ankylosing spondylitis: the global therapeutic target. (2018)

Spondyloarthritis: An expanding cast of cellular actors. (2018)

Spondyloarthritis: Harlequin or Chameleon? (2017)

Deaths Associated with Ankylosing Spondylitis in France from 1969 to 2009. (2017)